2023
DOI: 10.1038/s41467-023-41702-y
|View full text |Cite|
|
Sign up to set email alerts
|

Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs

Ganna Petruk,
Manoj Puthia,
Firdaus Samsudin
et al.

Abstract: There is a clinical need for conceptually new treatments that target the excessive activation of inflammatory pathways during systemic infection. Thrombin-derived C-terminal peptides (TCPs) are endogenous anti-infective immunomodulators interfering with CD14-mediated TLR-dependent immune responses. Here we describe the development of a peptide-based compound for systemic use, sHVF18, expressing the evolutionarily conserved innate structural fold of natural TCPs. Using a combination of structure- and in silico-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 70 publications
0
1
0
Order By: Relevance
“…Soluble CD14 molecules capture LPS and enhance its elimination in the liver through HDL binding. Thrombin-derived C peptides may inhibit the binding of LPS to CD14, as recently described [ 41 ].…”
Section: Discussionmentioning
confidence: 95%
“…Soluble CD14 molecules capture LPS and enhance its elimination in the liver through HDL binding. Thrombin-derived C peptides may inhibit the binding of LPS to CD14, as recently described [ 41 ].…”
Section: Discussionmentioning
confidence: 95%
“…Machine learning and deep learning breakthroughs in recent years have revolutionized the area of medical data analysis 15,16,17 . These strategies have shown great potential in a variety of healthcare applications, including medical picture analysis, disease diagnosis, drug development, and personalized medical care recommendations 18,19,20 .…”
Section: Introductionmentioning
confidence: 99%